Preoteomics, metabolomics and progenitor cells in acute coronary syndromes

Journal of Thrombosis and Thrombolysis

Volumn 22, Issue 1, 2006, Pages 85-88

  Becker, Richard C ^a   Andreotti, Felicita ^b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b CATHOLIC UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; MESSENGER RNA;

ACUTE CORONARY SYNDROME; BLOOD VESSEL INJURY; DRUG APPROVAL; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG RESEARCH; DRUG SAFETY; EDITORIAL; ENDOTHELIUM CELL; ENVIRONMENTAL FACTOR; FOOD AND DRUG ADMINISTRATION; GENE EXPRESSION PROFILING; GENE SEQUENCE; GENETIC CODE; GENETIC TRANSCRIPTION; GENOMICS; HEALTH CARE ORGANIZATION; HUMAN; METABOLOMICS; MOLECULAR INTERACTION; PATHOPHYSIOLOGY; PHARMACOGENOMICS; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN FUNCTION; PROTEIN STRUCTURE; PROTEOMICS; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY AND SPECIFICITY; TRANSCRIPTOMICS;

BIOLOGICAL MARKERS; CORONARY DISEASE; HUMANS; METABOLISM; MYOCARDIAL ISCHEMIA; PROTEOMICS; STEM CELLS;

EID: 33745253753     PISSN: 09295305     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11239-006-8871-4     Document Type: Editorial

References (20)

1. Ozaki K, Ohnishi Y, Iida A, et al (2002) Functional SNPs in the lymphotoxin-alpha gene that are associated with susceptibility to myocardial infarction. Nat Genet 32:650-654
2. Almasy L, Soria JM, Souto JC, et al (2003) A quantitative trait locus influencing free plasma protein S levels on human chromosome 1q: Results from the Genetic Analysis of Idiopathic Thrombophilia (GAIT) project. Arterioscler Thromb Vasc Biol 23:508-511
3. Feitosa MF, Borecki IB, Rich SS, et al (2002) Quantitative-trait loci influencing body-mass index reside on chromosome 7 and 13: The National Heart, Lung, and Blood Institute Family Heart Study. Am J Hum Genet 70:72-82
4. Hauser ER, Mooser V, Crossman DC, et al (2003) Design of the Genetics of Early Onset Cardiovascular Disease (GENECARD) study. Am Heart J 145:602-613
5. Venter JC, Adams, MD, Myers EW, et al (2001) The sequence of the human genome. Science 291:1301-1351
6. Loscalzo J (2003) Proteomics in cardiovascular biology and medicine. Circulation 108:380-383
7. De Cristofaro R, Rocca B, Marchiolo R, et al (2002) Plasma protein oxidation is associated with an increase of procoagulant markers causing an imbalance between pro- and anticoagulant pathways in healthy subjects. Thromb Haemost 87:58-67
8. Upchurch Jr GR, Ramdev N, Walsh MT, et al (1998) Prothrombotic consequences of the oxidation of fibrinogen and their inhibition by aspirin. J Thromb Thrombolysis 5:9-14
9. Nesheim M (2001) Myocardial infarction and the balance between fibrin deposition and removal. Ital Heart J 2:641-645
10. Vlassara H, Fuh H, Donnelly T, et al (1995) Advanced glycation endproducts promote adhesion molecule (VCAM-1, ICAM-1) expression and atheroma formation in normal rabbits. Mol Med 1:447-456
11. Sauls DL, Wolberg AS, Hoffman M (2003) Elevated plasma homocysteine leads to alterations in fibrin clot structure and stability: implications for the mechanism of thrombosis in hyperhomocysteinemia. J Thromb Haemost 1:300-306
12. Andreotti F, Pasceri V (1996) Ischaemic preconditioning. Lancet 348:204
13. Grant MB, Tarnuzzer RW, Caballero S, et al (1999) Adenosine receptor activation induces vascular endothelial growth factor in human retinal endothelial cells. Circ Res 85:699-706
14. Ohana G, Bar-Yehuda S, Barer F, et al (2001) Differential effect of adenosine on tumor and normal cell growth: Focus on the A3 adenosine receptor. J Cell Physiol 186:19-23
15. Yeh ET, Zhang S, Wu HD, et al (2003) Transdifferentiation of human peripheral blood CD34+-enriched cell population into cardiomyocytes, endothelial cells, and smooth muscle cells in vivo. Circulation 108:2070-2073
16. Shintani S, Murohara T, Ikeda H, et al (2001) Mobilization of endothelial progenitor cells in patients with acute myocardial infarction. Circulation 103:2776-2779
17. Vasa M, Fichtlscherer S, Aicher A, et al (2001) Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 89:e1-e7
18. Hill JM, Zalos G, Halcox JP, et al (2003) Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 348:593-600
19. Becker RC (2005) Cell-based models of coagulation: A paradigm in evolution. J Thromb Thrombolysis 20:65-68
20. Werner N, Kosiol S, Schiegl T, Ahlers P, Walenta K, Link A, Böhm M, Nickenig G (2005) Circulating Endothelial Progenitor Cells and Cardiovascular Outcomes. N Engl J Med 353:999-1007